2023 - Research.com Medicine in Belgium Leader Award
Christos Sotiriou mostly deals with Breast cancer, Internal medicine, Oncology, Cancer and Gene expression profiling. Christos Sotiriou interconnects Cancer research, Survival analysis, Bioinformatics and Pathology in the investigation of issues within Breast cancer. His Cancer research research incorporates elements of Surgical oncology, DNA microarray, Gene expression, Mutation and Regulation of gene expression.
The concepts of his Oncology study are interwoven with issues in Neoadjuvant therapy, Chemotherapy, Tumor-infiltrating lymphocytes, Hazard ratio and Biomarker. Christos Sotiriou has researched Cancer in several fields, including Genome, Immunology and Minimal residual disease. His Gene expression profiling study combines topics from a wide range of disciplines, such as Microarray analysis techniques, Tamoxifen and Breast cancer classification.
Christos Sotiriou spends much of his time researching Breast cancer, Internal medicine, Oncology, Cancer research and Cancer. His Breast cancer study combines topics in areas such as Gene expression, Gene expression profiling, Bioinformatics and Pathology. His studies deal with areas such as DNA microarray and Computational biology as well as Gene expression profiling.
His research in Chemotherapy, Trastuzumab, Clinical trial, Hazard ratio and Anthracycline are components of Internal medicine. His Oncology research is multidisciplinary, relying on both Neoadjuvant therapy, Proportional hazards model, Gynecology and Tumor-infiltrating lymphocytes. His Cancer research research is multidisciplinary, incorporating perspectives in Regulation of gene expression, PI3K/AKT/mTOR pathway and Immunology.
His primary areas of investigation include Breast cancer, Internal medicine, Oncology, Cancer research and Tumor-infiltrating lymphocytes. His Breast cancer research is multidisciplinary, incorporating elements of Cancer cell and Stromal tumor. His work is connected to Chemotherapy, Hazard ratio, Clinical trial, Confidence interval and Early breast cancer, as a part of Internal medicine.
His Oncology study integrates concerns from other disciplines, such as Odds ratio, Trastuzumab, Multivariate analysis, Adverse effect and Cohort. Christos Sotiriou has included themes like Cancer, Metastasis, Stroma, DNA methylation and Immune system in his Cancer research study. His Triple-negative breast cancer research includes themes of Neoadjuvant therapy and Gene expression profiling.
His main research concerns Breast cancer, Internal medicine, Oncology, Cancer research and Tumor-infiltrating lymphocytes. Christos Sotiriou studies Breast cancer, focusing on Triple-negative breast cancer in particular. His Triple-negative breast cancer research integrates issues from Cancer immunology, Transcriptome, Nivolumab and Gene expression profiling.
His Oncology research incorporates themes from Survival rate, Multivariate analysis, Estrogen receptor, Digital polymerase chain reaction and Proportional hazards model. His study in Cancer research is interdisciplinary in nature, drawing from both Cancer cell, Carcinogenesis, Adjuvant, Metastasis and Regulation of gene expression. The Tumor-infiltrating lymphocytes study combines topics in areas such as Biomarker, Chemotherapy, Tumor immunology and Digital pathology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
Christos Sotiriou;Soek-Ying Neo;Lisa M McShane;Edward L Korn.
Proceedings of the National Academy of Sciences of the United States of America (2003)
Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis
Christos Sotiriou;Pratyaksha Wirapati;Sherene Loi;Adrian Harris.
Journal of the National Cancer Institute (2006)
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
R. Salgado;C. Denkert;S. Demaria;N. Sirtaine.
Annals of Oncology (2015)
International network of cancer genome projects
Thomas J. Hudson;Thomas J. Hudson;Warwick Anderson;Axel Aretz;Anna D. Barker.
Gene-expression signatures in breast cancer.
Christos Sotiriou;Lajos Pusztai.
The New England Journal of Medicine (2009)
Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
Mitch Dowsett;Torsten O. Nielsen;Roger A’Hern;John Bartlett.
Journal of the National Cancer Institute (2011)
The landscape of cancer genes and mutational processes in breast cancer
Philip J. Stephens;Patrick S. Tarpey;Helen Davies;Peter Van Loo;Peter Van Loo.
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
Serena Nik-Zainal;Serena Nik-Zainal;Helen Davies;Johan Staaf;Manasa Ramakrishna.
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
Fatima Cardoso;Laura J. van’t Veer;Jan Bogaerts;Leen Slaets.
The New England Journal of Medicine (2016)
Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast Cancer
Marc Buyse;Sherene Loi;Laura van't Veer;Giuseppe Viale.
Journal of the National Cancer Institute (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: